Surprisingly, every individual tested showed, to a bigger or lesser extent, responses against GAD, measured as percentage of GAD-specific CD154+ CD69+ cells (GSCs) (Fig. 1D and Supplementary Fig. 2c, d), with no differences between HD and T1D patients (Fig. 1d, and Supplementary Table 2. Here, CD69 is linked to Huntington disease.